RBC Bioscience Corporation(TW:6848)
NT$20.95+0.80 (+3.97%)
TW:6848
RBC Bioscience Corporation Revenue
NT$20.95
At close:+0.80 (+3.97%)
RBC Bioscience Corporation (6848) Revenue
RBC Bioscience Corporation Revenue
RBC Bioscience Corporation had a revenue of 108.59M in the quarter ending Jun 30, 2026, with -3.05%. This bring the company's revenue in the last twelve months to 220.60M, Increased 0.41%. In the fiscal year ending Dec 31, 2025, RBC Bioscience Corporation had annual revenue of 219.71M with 7.05% growth.
- Revenue (ttm)
- 220.60M
- Revenue Growth
- 9.29%
- P/S Ratio
- 1.36
- Revenue/Employee
- TWD 4,394,140
- Employees
- 50
- Market Cap
- TWD 299.02M
Revenue Chart
RBC Bioscience Corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 219.71M | 14.46M | 7.05% |
| Dec 31, 2024 | 205.25M | 32.78M | 19.01% |
| Dec 31, 2023 | 172.47M | -1.42M | -0.82% |
| Dec 31, 2022 | 173.89M | -77.29M | -30.77% |
| Dec 31, 2021 | 251.18M | -323.98M | -56.33% |
| Dec 31, 2020 | 575.16M | 413.49M | 255.74% |
| Dec 31, 2019 | 161.68M | 35.65M | 28.29% |
| Dec 31, 2018 | 126.03M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.